Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
98.63
-1.23 (-1.23%)
Feb 10, 2025, 7:27 PM EST - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Encompass Health stock have an average target of 107.38, with a low estimate of 95 and a high estimate of 120. The average target predicts an increase of 8.87% from the current stock price of 98.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Encompass Health stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +21.67% | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | +19.64% | Feb 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +11.53% | Oct 30, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | +17.61% | Oct 30, 2024 |
| Barclays | Barclays | Buy Maintains $109 → $116 | Buy | Maintains | $109 → $116 | +17.61% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
5.90B
from 5.37B
Increased by 9.73%
Revenue Next Year
6.40B
from 5.90B
Increased by 8.62%
EPS This Year
4.82
from 4.46
Increased by 8.03%
EPS Next Year
5.35
from 4.82
Increased by 11.04%
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 6.3B | 6.8B |
| Avg | 5.9B | 6.4B |
| Low | 5.6B | 6.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 16.6% | 15.8% |
| Avg | 9.7% | 8.6% |
| Low | 5.0% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.51 | 6.35 | 5.55 | |
| Avg | 4.82 | 5.35 | 5.34 | |
| Low | 4.33 | 4.68 | 5.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 23.5% | 31.8% | 3.8% | |
| Avg | 8.0% | 11.0% | -0.2% | |
| Low | -2.9% | -2.8% | -3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.